Rein Therapeutics
RNTX
#9741
Rank
NZ$62 M
Marketcap
$2.86
Share price
-4.52%
Change (1 day)
-71.72%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2024 (TTM): -NZ$48.03 Million

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$26.46 Million, an increase over its 2022 earnings that were of -NZ$47.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$48.03 Million81.5%
2023 -NZ$26.46 Million-44.49%
2022 -NZ$47.67 Million3.92%
2021 -NZ$45.87 Million29.81%
2020 -NZ$35.34 Million-31.58%
2019 -NZ$51.65 Million-6.1%
2018 -NZ$55 Million38.66%
2017 -NZ$39.67 Million26.63%
2016 -NZ$31.33 Million